Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cumberland Pharmaceuticals (CPIX) Long-Term Deferred Tax (2016 - 2020)

Cumberland Pharmaceuticals' Long-Term Deferred Tax history spans 11 years, with the latest figure at $21802.0 for Q3 2020.

  • On a quarterly basis, Long-Term Deferred Tax fell 50.0% to $21802.0 in Q3 2020 year-over-year; TTM through Sep 2020 was $21802.0, a 50.0% decrease, with the full-year FY2019 number at $21802.0, down 75.0% from a year prior.
  • Long-Term Deferred Tax hit $21802.0 in Q3 2020 for Cumberland Pharmaceuticals, roughly flat from $21802.0 in the prior quarter.
  • Over the last five years, Long-Term Deferred Tax for CPIX hit a ceiling of $3.5 million in Q1 2017 and a floor of $21802.0 in Q4 2019.
  • Historically, Long-Term Deferred Tax has averaged $523162.6 across 5 years, with a median of $65407.5 in 2017.
  • The widest YoY moves for Long-Term Deferred Tax: up 0.0% in 2018, down 97.53% in 2018.
  • Tracing CPIX's Long-Term Deferred Tax over 5 years: stood at $3.1 million in 2016, then tumbled by 97.2% to $87210.0 in 2017, then changed by 0.0% to $87210.0 in 2018, then tumbled by 75.0% to $21802.0 in 2019, then changed by 0.0% to $21802.0 in 2020.
  • Business Quant data shows Long-Term Deferred Tax for CPIX at $21802.0 in Q3 2020, $21802.0 in Q2 2020, and $21802.0 in Q1 2020.